VITAL Shows No Benefit of Vitamin D, n-3 Fatty Acids on CV Events or Cancer. acc.org/latest-in-cardiology (dostępny pełen tekst)
Supplementation of vitamin D or marine n-3 fatty acids may not lower the incidence of major cardiovascular events or invasive cancer vs. placebo, according to results from the VITAL trial presented Nov. 10 at AHA 2018 in Chicago, IL, and simultaneously published in two papers in the New England Journal of Medicine.
Kongres AHA 2018, 10 listopada